TY - JOUR
T1 - Do health service staff support the implementation of voluntary assisted dying at their workplace?
AU - Fuscaldo, Giuliana
AU - Gwini, Stella May
AU - Larsen, Richard
AU - Venkataramani, Amarita
N1 - Funding Information:
The authors thank our New Zealand colleagues, Michael Wilson (Wilson Associates, Australia), Pam Oliver (Pam Oliver Ltd., Research and Evaluation, New Zealand) and Phillipa Malpas (Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand) for sharing their survey and for helpful discussions in the preparation of the our study. The authors also thank Professors Charlie Corke (University Hospital Geelong and Faculty of Health, School of Medicine, Deakin University) and Sean Jespersen (Executive Director Medical Services, Chief Medical Officer at The Royal Victorian Eye and Ear Hospital) for comments on early drafts and to all of the staff who gave their time to contribute to this study.
Publisher Copyright:
© 2021 Royal Australasian College of Physicians
PY - 2021/10
Y1 - 2021/10
N2 - Background: On 29 November 2017, the Victorian Parliament passed the Voluntary Assisted Dying (VAD) Act 2017, which came into effect on 19 June 2019. Aims: To investigate whether staff from a large regional health service support the legalisation of VAD and the implementation of VAD at their workplace. Methods: Staff were invited to complete an anonymous online survey comprising both closed- and open-ended questions. Results: Thirty-eight percent of the workforce (n = 1624) responded to the survey. Most participants supported the legalisation of VAD (88%), the provision of eligibility assessment and/or the administration of VAD within the health service (80%). There were negligible differences in support for VAD by role; however, specialist doctors were significantly less supportive (65%). Approximately half of the respondents expressed concern about monitoring (49%) or implementation (53%) of VAD. Concerns were also raised about assessment of eligibility, support for staff involved in VAD and pressure on both patients and staff to participate. Nearly three-quarters (71%) of participants agreed that if the health service offers VAD services, a special unit or facility should be available. Conclusions: This study found that health workers have concerns about the implementation of VAD at their workplace but are generally supportive. This article provides information for health services considering the implementation of VAD, about staff concerns and issues that need to be addressed for the successful introduction of VAD.
AB - Background: On 29 November 2017, the Victorian Parliament passed the Voluntary Assisted Dying (VAD) Act 2017, which came into effect on 19 June 2019. Aims: To investigate whether staff from a large regional health service support the legalisation of VAD and the implementation of VAD at their workplace. Methods: Staff were invited to complete an anonymous online survey comprising both closed- and open-ended questions. Results: Thirty-eight percent of the workforce (n = 1624) responded to the survey. Most participants supported the legalisation of VAD (88%), the provision of eligibility assessment and/or the administration of VAD within the health service (80%). There were negligible differences in support for VAD by role; however, specialist doctors were significantly less supportive (65%). Approximately half of the respondents expressed concern about monitoring (49%) or implementation (53%) of VAD. Concerns were also raised about assessment of eligibility, support for staff involved in VAD and pressure on both patients and staff to participate. Nearly three-quarters (71%) of participants agreed that if the health service offers VAD services, a special unit or facility should be available. Conclusions: This study found that health workers have concerns about the implementation of VAD at their workplace but are generally supportive. This article provides information for health services considering the implementation of VAD, about staff concerns and issues that need to be addressed for the successful introduction of VAD.
UR - https://www.scopus.com/pages/publications/85117092290
U2 - 10.1111/imj.15285
DO - 10.1111/imj.15285
M3 - Article
C2 - 33710752
AN - SCOPUS:85117092290
SN - 1444-0903
VL - 51
SP - 1636
EP - 1644
JO - Internal Medicine Journal
JF - Internal Medicine Journal
IS - 10
ER -